These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 949893)

  • 21. Post-coital intrauterine device insertion - a further evaluation.
    Black TR; Goldstuck ND; Spence A
    Contraception; 1980 Dec; 22(6):653-8. PubMed ID: 7214912
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Performance of the frameless IUD (Flexigard prototype inserter) and the TCu380A after six years as part of a WHO multicenter randomized comparative clinical trial in parous women.
    Hui-Qin L; Zhuan-Chong F; Yu-Bao W; Yiao-Lin H; Van Kets H; Wildemeersch D
    Adv Contracept; 1999; 15(3):201-9. PubMed ID: 11019951
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Canadian Contraception Consensus (Part 3 of 4): Chapter 7--Intrauterine Contraception.
    Black A; Guilbert E; Costescu D; Dunn S; Fisher W; Kives S; Mirosh M; Norman W; Pymar H; Reid R; Roy G; Varto H; Waddington A; Wagner MS; Whelan AM; Mansouri S
    J Obstet Gynaecol Can; 2016 Feb; 38(2):182-222. PubMed ID: 27032746
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Experience with the copper 7 intrauterine device in an adolescent population.
    Kulig JW; Rauh JL; Burket RL; Cabot HM; Brookman RR
    J Pediatr; 1980 Apr; 96(4):746-50. PubMed ID: 7359288
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interactions between intrauterine contraceptive device use and breast-feeding status at time of intrauterine contraceptive device insertion: analysis of TCu-380A acceptors in developing countries.
    Farr G; Rivera R
    Am J Obstet Gynecol; 1992 Jul; 167(1):144-51. PubMed ID: 1442918
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical experience with the Cu-7 intrauterine device.
    Bernstein GS; Israel R; Seward P; Mishell DR
    Contraception; 1972 Aug; 6(2):99-107. PubMed ID: 4568279
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Copper-7 intrauterine device (Gravigard). Report of experience].
    Jürgensen O; Stenzel I; Wirth A; Sina D; Taubert HD
    Fortschr Med; 1976 Mar; 94(9):515-21. PubMed ID: 964914
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intrauterine devices: present and future.
    Guillebaud J
    Int J Gynaecol Obstet; 1980; 18(5):325-32. PubMed ID: 6110576
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of prior pregnancy and combined oral contraceptives on baseline menstrual blood loss and bleeding response to intrauterine devices.
    Andrade AT; de Souza JP; Rowe PJ; Shaw ST
    Contraception; 1979 Jul; 20(1):19-26. PubMed ID: 477314
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The introduction of postpartum intrauterine devices in the People's Republic of China.
    Wen ZS; Lin L; Laufe LE; Dixon B
    Int J Gynaecol Obstet; 1983 Apr; 21(2):151-4. PubMed ID: 6136435
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immediate postpartum insertion of a copper-wired intrauterine contraceptive device, the MLCu250.
    Thiery M; Van Der Pas H; Delbeke L; Van Kets H
    Br J Obstet Gynaecol; 1979 Aug; 86(8):654-8. PubMed ID: 497136
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Four years of experience with the TCu 380A intrauterine contraceptive device.
    Sivin I; Tatum HJ
    Fertil Steril; 1981 Aug; 36(2):159-63. PubMed ID: 7262334
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A study of the copper T intrauterine contraceptive device (TCu 200) in nulliparous women.
    Mishell DR; Israel R; Freid N
    Am J Obstet Gynecol; 1973 Aug; 116(8):1092-6. PubMed ID: 4721138
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An evaluation of the TCu 380Ag and the Multiload Cu375.
    Cole LP; Potts DM; Aranda C; Behlilovic B; Etman ES; Moreno J; Randic L
    Fertil Steril; 1985 Feb; 43(2):214-7. PubMed ID: 3881295
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Intrauterine contraceptive devices. Mode of action, experiences, complications (author's transl)].
    Ludwig H
    Geburtshilfe Frauenheilkd; 1976 Feb; 36(2):97-108. PubMed ID: 943359
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessing the intrauterine device.
    Mishell DR
    Fam Plann Perspect; 1975; 7(3):103-11. PubMed ID: 1140345
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The first year of clinical experience with concurrent post abortal insertion of copper "T" 200.
    Rajan R; Usha L; Venkitakrishnan S
    J Obstet Gynaecol India; 1979 Apr; 29(2):248-52. PubMed ID: 12335887
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Experience with three different models of the Copper T intrauterine contraceptive device in nulliparous women.
    Roy S; Cooper D; Mishell DR
    Am J Obstet Gynecol; 1974 Jun; 119(3):414-7. PubMed ID: 4827383
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Important factors in the use-effectiveness of the copper-T-200 IUD.
    Akinla O; Luukkainen T; Timonen H
    Contraception; 1975 Dec; 12(6):697-707. PubMed ID: 1204355
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Performances of copper T 380A and multiload copper 375/250 intrauterine contraceptive devices in a comparative clinical trial.
    Arowojolu AO; Otolorin EO; Ladipo OA
    Afr J Med Med Sci; 1995 Mar; 24(1):59-65. PubMed ID: 7495202
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.